# Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis

> **NCT03471455** · PHASE2 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 100 (estimated)

## Conditions studied

- Tinea

## Interventions

- **DRUG:** Isotretinoin
- **DRUG:** Terbinafine
- **DRUG:** Itraconazole 200 mg

## Key facts

- **NCT ID:** NCT03471455
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03471455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03471455, "Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03471455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*